INDP Rasio cepet Indaptus Therapeutics

The market capitalization trend for Indaptus Therapeutics (INDP) on the GURU.Markets platform helps assess the successful implementation of bacterial platforms for cancer treatment and M&A prospects, where the indicator stands at 20.16. The business relies on partnerships with medical centers for the therapy of resistant tumors. The stability of Indaptus Therapeutics (INDP) is supported by the neutral status of biomedicine, which minimizes the impact of global conflicts on operational activities.

Indaptus Therapeutics (INDP) maintains a strategic market advantage through its innovative patents in tumor immunotherapy. This metric translates these intangible assets into cash and accounts receivable, excluding illiquid inventories. Such an approach measures the issuer's ability to meet short-term obligations under strict FDA oversight. By analyzing the cash ratio, an investor determines the business's actual financial resilience.